Atrial fibrillation, Chronic subdural hematoma
Conditions
Brief summary
Thromboembolic events (ischemic stroke, systemic embolism), Hemorrhagic events, Vascular death
Detailed description
All-cause mortality, modified Rankin Scale, Reoperation of ipsilateral hematoma, Number and type of unscheduled emergency radiological examinations, Number of emergency department visits, Postoperative total hospitalization days, counted from the day of surgery, Separation of the components of the primary outcome
Interventions
DRUGEDOXABAN
DRUGAPIXABAN
DRUGWARFARIN
DRUGDABIGATRAN ETEXILATE
DRUGRIVAROXABAN
Sponsors
HUS-Yhtymae
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thromboembolic events (ischemic stroke, systemic embolism), Hemorrhagic events, Vascular death | — |
Secondary
| Measure | Time frame |
|---|---|
| All-cause mortality, modified Rankin Scale, Reoperation of ipsilateral hematoma, Number and type of unscheduled emergency radiological examinations, Number of emergency department visits, Postoperative total hospitalization days, counted from the day of surgery, Separation of the components of the primary outcome | — |
Countries
Finland, Sweden
Outcome results
None listed